Page 37 - Kessler Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail IMAGE: Dr. Wylie, director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, specializes in the implementation of neuroimaging techniques in rehabilitation research. view more  Credit: Kessler Foundation East Hanover, NJ. March 8, 2021. Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue. This finding, the first of its kind, was reported in Scientific Reports on December 14, 2020 in the open access article, "Using functional connectivity changes associated with c...

nTIDE February 2021 Jobs Report: Modest Job Gains Provide Hope for Economic Recovery Share Article The job numbers increased slightly as the economy strived to recover from the impact of the COVID-19 pandemic, according to today’s National Trends in Disability Employment – Monthly Update (nTIDE), issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). “In contrast to January, we saw a slight improvement in the employment-to-population ratio,” said John O’Neill, PhD, director of the Center for Employment and Disability Research at Kessl...

Kessler team receives funding to study factors leading to osteoarthritis after knee injury Gerard Malanga, MD, and Nathan Hogaboom, PhD, of Kessler Foundation received a $185,707 award from The Geneva Foundation (Geneva) to study factors contributing to the development of osteoarthritis following acute knee injuries, a common disabling condition among active-duty military personnel. The funding supports Kessler Foundation's participation as a collaborative partner in Musculoskeletal Injury and Rehabilitation Research for Operational Readiness (MIRROR) headquartered at the Uniformed Services U...

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS). John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, "A Biomarker for Cognitive Fatigue in MS using Functional Imaging". The study team includes Glenn Wylie, DPhil, director of the Rocc...

 E-Mail IMAGE: Dr. DeLuca is senior vice president of Research and Training at Kessler Foundation and professor of neurology and physical medicine and rehabilitation at Rutgers New Jersey Medical School. He... view more  Credit: Kessler Foundation East Hanover, NJ. February 8, 2021 - Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS). John DeLuca, PhD, senior vice presi...